Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Elekta wins expanded FDA nod for Gamma Knife radiosurgery system | 2 | MassDevice | ||
Mi | Elekta's Gamma Knife Gains FDA Clearance For Drug-Resistant Temporal Lobe Epilepsy | 1 | RTTNews | ||
ELEKTA AB ADR Aktie jetzt für 0€ handeln | |||||
Mi | Elekta AB: Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy | 59 | GlobeNewswire (Europe) | New indication expands treatment options for neurosurgeons managing complex epilepsy cases
ATLANTA - Elekta (EKTA-B.ST) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k)... ► Artikel lesen | |
11.06. | Citi bekräftigt Verkaufsempfehlung für Elekta-Aktie | 19 | Investing.com Deutsch | ||
11.06. | CITI REITERATES SELL RATING ON ELEKTA STOCK AMID PRICING SHIFT | 7 | Investing.com | ||
10.06. | Elekta shares down after SEK 4.9 bln order cancellation; new CEO appointed | 16 | Investing.com | ||
09.06. | Elekta announces a new CEO | 10 | MassDevice | ||
09.06. | Elekta AB: Elekta appoints Jakob Just-Bomholt as new President and CEO | 184 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today the appointment by the Board of Directors of Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.
Jakob, a... ► Artikel lesen | |
28.05. | Elekta AB GAAP EPS of -SEK 1.01, revenue of SEK 5.16B; initiates Q1 outlook | 18 | Seeking Alpha | ||
28.05. | Elekta AB: Year-end report May-April 2024/25 | 211 | GlobeNewswire (Europe) | Fourth quarterIn constant exchange rates, net sales increased by 6 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 5,156 M (5,023).Book-to-bill ratio... ► Artikel lesen | |
03.05. | Elekta AB: Clinical trial shows more precise radiotherapy using Elekta Unity MR-Linac preserves sexual function in men with prostate cancer | 166 | GlobeNewswire (Europe) | ERECT trial used MR-guidance to spare nerves and blood vessels essential for achieving and maintaining an erection
VIENNA - Elekta (EKTA-B.ST) today announced that use of its 1.5T Elekta Unity MR-Linac... ► Artikel lesen | |
07.03. | Dividendenbekanntmachungen (07.03.2025) | 18.666 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2177 EUR AEW UK REIT PLC GB00BWD24154 0,02 GBP EUR AMERISAFE INC US03071H1005 0... ► Artikel lesen | |
26.02. | Elekta says its CEO is stepping down | 15 | MassDevice | ||
26.02. | Elekta AB: Gustaf Salford to leave position as President and CEO of Elekta as of March 6 | 396 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today that Gustaf Salford, President and CEO, and the Board of Directors, have decided that Gustaf will leave Elekta as of March 6. Jonas Bolander, Executive... ► Artikel lesen | |
21.02. | Elekta shares tumble as company lowers full-year outlook | 9 | Investing.com | ||
21.02. | Elekta AB reports Q3 results | 6 | Seeking Alpha | ||
21.02. | Elekta AB: Q3 Report, November-January 2024/25 | 295 | GlobeNewswire (Europe) | Third quarterIn constant exchange rates, net sales increased by 2 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 4,695 M (4,537).Net sales were negatively... ► Artikel lesen | |
29.01. | Bernstein upgrades Coloplast, Elekta; Philips still top pick | 55 | Investing.com | ||
27.11.24 | Elekta AB: Q2 Report, August-October 2024/25 | 422 | GlobeNewswire (Europe) | Second quarterIn constant exchange rates, net sales decreased by 4 percent mainly due to Europe and Latin America. Reported sales decreased by 8 percent amounting to SEK 4,341 M (4,732).Elekta Evo has... ► Artikel lesen | |
09.09.24 | Dividendenbekanntmachungen (09.09.2024) | 6.706 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADMIE IPTO HOLDING SA GRS518003009 - 0,0582 EUR AFRICA OIL CORP CA00829Q1019 0,025 USD 0,0225 EUR ALEXANDERWERK AG DE000A37FTW0 - 1... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FAMICORD | 5,100 | +2,00 % | Original-Research: FamiCord AG (von Montega AG): Kaufen | Original-Research: FamiCord AG - von Montega AG 06.06.2025 / 17:08 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den Inhalt der Mitteilung... ► Artikel lesen | |
SPINEWAY | 0,110 | -3,51 % | Spineway: GMED approval for new production line dedicated to ESP prostheses - First production of LP-ESP intervertebral disc prostheses | Press release Ecully, July 3, 2025 - 6:30 p.m. SPINEWAY GMED approval for new production line dedicated to ESP prostheses First production of LP-ESP intervertebral disc prostheses Spineway... ► Artikel lesen | |
PETMED EXPRESS | 3,237 | +0,28 % | UNGLAUBLICHE Sondermeldung bei Petmed Express Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
QUIDELORTHO | 23,200 | -0,85 % | QuidelOrtho Corporation: QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs | New executives bring deep expertise to elevate quality and accelerate innovation across global operations SAN DIEGO, July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)... ► Artikel lesen | |
ELEKTA | 4,374 | +2,01 % | Elekta AB: Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy | New indication expands treatment options for neurosurgeons managing complex epilepsy cases
ATLANTA - Elekta (EKTA-B.ST) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k)... ► Artikel lesen | |
STAAR SURGICAL | 16,165 | -1,16 % | STAAR Surgical Q1 2025: Umsatzeinbruch in China, Wachstum in globalen Märkten/n | ||
TELEFLEX | 99,50 | -0,50 % | Teleflex Incorporated: Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business | WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition... ► Artikel lesen | |
NOVACYT | 0,453 | -1,41 % | Novacyt S.A. - Launch of LightBench® Discover | ||
M3 INC | 10,700 | -2,73 % | M3-Aktie leicht im Plus (10,90 €) | An der Börse liegt die M3-Aktie zur Stunde im Plus. Der jüngste Kurs betrug 10,90 Euro. An der Börse liegt die Aktie von M3 gegenwärtig im Plus. Die Aktie legte um 0,4 Euro zu. Am Aktienmarkt zahlen... ► Artikel lesen | |
INSPIRE MEDICAL SYSTEMS | 106,30 | -2,66 % | Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook | Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire... ► Artikel lesen | |
AMBEA | 10,500 | 0,00 % | Ambea AB: Ambea's interim report January - March 2025 | Entry into Finnish market enables increased Nordic growth
CEO comments:
After the end of the quarter, we completed the acquisition of Validia in Finland, making us the only care provider with a strong... ► Artikel lesen | |
SHIP HEALTHCARE | 11,900 | 0,00 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
BUMRUNGRAD HOSPITAL | 3,720 | 0,00 % | Dividendenbekanntmachungen (19.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALL FOR ONE GROUP SE DE0005110001 - 1,6 EUR AP MOELLER-MAERSK A/S A DK0010244425 1120 DKK 150,155 EUR AP MOELLER-MAERSK A/S B DK0010244508 1120... ► Artikel lesen | |
MERCATOR MEDICAL | 11,000 | +3,58 % | Mercator Medical wants to buy back up to 124,000 of its own shares | ||
SIEMENS HEALTHINEERS | 47,970 | +0,15 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |